APRIENT Trademark

Trademark Overview

On Friday, August 28, 2015, a trademark application was filed for APRIENT with the United States Patent and Trademark Office. The USPTO has given the APRIENT trademark a serial number of 86741204. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 21, 2022. This trademark is owned by Neurocrine Biosciences, Inc.. The APRIENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, muscle dystonia, neurological-related movement disorders and involuntary tics resulting from neurological disorders
aprient

General Information

Serial Number86741204
Word MarkAPRIENT
Filing DateFriday, August 28, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, muscle dystonia, neurological-related movement disorders and involuntary tics resulting from neurological disorders
Translation of Words in MarkThe wording "Aprient" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 2, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 21, 2021EXTENSION 5 GRANTED
Tuesday, July 13, 2021EXTENSION 5 FILED
Monday, July 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 13, 2021TEAS EXTENSION RECEIVED
Thursday, December 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 22, 2020EXTENSION 4 GRANTED
Tuesday, December 22, 2020EXTENSION 4 FILED
Tuesday, December 22, 2020TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020EXTENSION 3 GRANTED
Wednesday, June 17, 2020EXTENSION 3 FILED
Wednesday, June 17, 2020TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 3, 2020EXTENSION 2 GRANTED
Friday, January 3, 2020EXTENSION 2 FILED
Friday, January 3, 2020TEAS EXTENSION RECEIVED
Friday, June 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2019EXTENSION 1 GRANTED
Wednesday, June 5, 2019EXTENSION 1 FILED
Wednesday, June 5, 2019TEAS EXTENSION RECEIVED
Tuesday, January 15, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 12, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 12, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 11, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 19, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 19, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 11, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, April 11, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 11, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, April 11, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, September 28, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 28, 2015LETTER OF SUSPENSION E-MAILED
Monday, September 28, 2015SUSPENSION LETTER WRITTEN
Monday, September 28, 2015EXAMINER'S AMENDMENT ENTERED
Monday, September 28, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 28, 2015EXAMINERS AMENDMENT E-MAILED
Monday, September 28, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 22, 2015ASSIGNED TO EXAMINER
Wednesday, September 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 1, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

aprient neurological disorders related uterine fibroids endometriosis system diseases tardive insomnia